15.02.2013
- Merck & Co has agreed to pay $688 million to settle two U.S. class-action lawsuits by shareholders who said they lost money because the company concealed the poor results of a...
13.02.2013
- Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to...
31.01.2013
- Life Sciences - The pace of medical discovery is accelerating, increasing the pressure on life sciences researchers to complete clinical trials quickly, efficiently and with the...
13.01.2013
- U.S. drugmaker Merck & Co said it is taking steps to suspend availability of its drug Tredaptive after the medicine, used to raise "good" HDL cholesterol, failed to prevent heart...
28.11.2012
- Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being attacked...
22.11.2012
- Roche has offered an olive branch to scientific critics in a bid to end a bitter row over blockbuster flu drug Tamiflu that has led to calls for a boycott of the Swiss drugmaker's...
11.10.2012
- GlaxoSmithKline, criticised in the past for keeping important information about its medicines to itself, is to lift the lid on more of its drug secrets. Three months after GSK was...
15.07.2012
- Europe's medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl...
